Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Tax, Health Reform Close To Reality As Conference Committee Meets

This article was originally published in The Gray Sheet

Executive Summary

As the House and Senate work to meld their respective 2,000-page health care reform bills into a single politically viable plan, the device industry remains most intently focused on a mere seven pages of each: the device tax provisions

You may also be interested in...



Supreme Court Health Reform Oral Arguments Leave Open Questions

Device firms should not stop preparing for the 2.3% excise tax, scheduled to take effect next January. Still, justices during oral arguments March 26-28 did not take off the table the prospect of ruling the entire health care reform legislation void.

House Dems Settle On 2.9% Excise Tax On Device Sales Starting In 2013

A 2.9% excise tax would be imposed on device manufacturers beginning in 2013 under a House reconciliation bill released by Democrats March 18

House Dems Settle On 2.9% Excise Tax On Device Sales Starting In 2013

A 2.9% excise tax would be imposed on device manufacturers beginning in 2013 under a House reconciliation bill released by Democrats March 18

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028329

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel